Greenwich Lifesciences
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $3 | $0 | $0 | $0 |
Gross Profit | 1 | |||
EBITDA | -5,657 | -4,151 | -4,024 | |
EBIT | 7,328 | -4,025 | ||
Net Income | -5,657 | -7,922 | -4,151 | -4,025 |
Net Change In Cash | 3 | 0 | 0 | 0 |
Free Cash Flow | -4,702 | -3,174 | -2,671 | -2,233 |
Cash | 10,505 | 6,178 | 3,806 | 3,125 |
Basic Shares | 14,565 | 14,298 | 13,641 | 13,370 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1 | -3 | -3 | -3 |
EBITDA | -19,356 | -17,410 | -8,888 | -7,821 |
EBIT | -19,358 | -17,414 | -8,891 | -7,825 |
Net Income | -19,358 | -17,414 | -8,891 | -7,825 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -9,913 | -7,266 | -6,478 | -6,200 |
Cash | 6,178 | 4,091 | 6,989 | 13,468 |
Basic Shares | 13,534 | 13,014 | 12,848 | 12,913 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.39 |
2025-12-31 | -$0.58 |
2025-09-30 | -$0.30 |
2025-06-30 | -$0.30 |